Penlac and Humalog drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Penlac (ciclopirox) and Humalog (insulin lispro recombinant). Common drug interactions include fall among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Penlac and Humalog. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Penlac?

Penlac has active ingredients of ciclopirox. eHealthMe is studying from 492 Penlac users. Check the latest studies of Penlac.

What is Humalog?

Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.



On Jul, 07, 2026

28 people who take Penlac and Humalog together, and have interactions are studied.

Penlac and Humalog drug interactions.

What are the common drug interactions of Penlac and Humalog, by gender? *:

female:

  1. Fall
  2. Head injury
  3. Renal failure (kidney dysfunction)
  4. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  5. Nephrolithiasis (calculi in the kidneys)
  6. Dehydration (dryness resulting from the removal of water)
  7. Dizziness
  8. Dependence on respirator
  9. Erythrasma (skin disease that causes brown, scaly skin patches)
  10. Fluid overload (too much fluid in the blood)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Asthenia (weakness)
  4. Blood pressure increased
  5. Coronary arterial stent insertion
  6. Headache (pain in head)
  7. Heart rate increased
  8. Thirst
  9. Wheezing (a high-pitched whistling sound made while you breath)

What are the common drug interactions of Penlac and Humalog, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Dehydration (dryness resulting from the removal of water)
  2. Dizziness
  3. Erythrasma (skin disease that causes brown, scaly skin patches)
  4. Headache (pain in head)
  5. Asthenia (weakness)
  6. Blood pressure increased
  7. Coronary arterial stent insertion
  8. Cough
  9. Diarrhoea
  10. Heart rate increased

50-59:

  1. Blood pressure decreased
  2. Cerebral haemorrhage (bleeding within the brain)
  3. Fall
  4. Head injury
  5. Renal failure (kidney dysfunction)
  6. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  7. Nephrolithiasis (calculi in the kidneys)

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Cardiac failure congestive
  4. Drug hypersensitivity

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 53.57%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 53.57%
  3. Cerebral Haemorrhage (bleeding within the brain): 5 people, 17.86%
  4. Asthma: 5 people, 17.86%
  5. Immunodeficiency: 3 people, 10.71%
  6. High Blood Cholesterol: 3 people, 10.71%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
  8. Neuropathy Peripheral (surface nerve damage): 2 people, 7.14%
  9. High Blood Pressure: 2 people, 7.14%
  10. Gout (uric acid crystals building up in the body): 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Penlac and Humalog?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Penlac and Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Penlac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Humalog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Penlac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Humalog and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclopirox and insulin lispro recombinant (the active ingredients of Penlac and Humalog, respectively), and Penlac and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: